Consequences of proctology surgery (LARS)

UEG Week Recordings UEG Week Posters Online courses Guidelines Mistakes in... Podcasts Webinars

new

Gut Guide online

Search

Visit ueg.eu Create myUEG account Log In

Search

Visit ueg.eu Create myUEG account Log In

Filters:

UEG Online Course

accredited

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Consequences of proctology surgery (LARS)

Harald Rosen, Andreas Rink, Peter Christensen, Franco Marinello

Summary

AI Generated

Low Anterior Resection Syndrome (LARS) is a common and persistent spectrum of bowel dysfunction affecting the majority of patients after rectal surgery despite sphincter-preserving techniques.

LARS includes symptoms of incontinence, constipation, urgency, and stool clustering that can severely impact quality of life.
The prevalence of LARS is alarmingly high, affecting a majority of patients undergoing rectal surgery.
Symptoms can persist for years after surgical treatment.
This material is intended for gastroenterologists, colorectal surgeons, oncologists, nurses, stoma therapists, and primary care physicians.

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Overview

Bowel function is significantly affected after rectal surgery. While sphincter-preserving techniques aim to maintain anal continence, many patients experience a spectrum of bowel dysfunction, collectively known as Low Anterior Resection Syndrome (LARS). LARS includes symptoms such as incontinence, constipation, urgency, and stool clustering, which can severely impact a patient’s quality of life. The prevalence of LARS is alarmingly high, affecting a majority of patients, and symptoms can persist for years after surgical treatment.

Target audience

Gastroenterologists
Colorectal surgeons
Oncologists
Nurses/Stoma therapists
Primary care physicians

Event

Consequences of proctology surgery (LARS)

Topics

Accreditation status

accredited

Duration

1 hour

Published

2026

More Like This:

Oesophageal Cancer

Ana-Maria Bucalau

Obesity part 1: Surgical and endoscopic treatment

Alia Hadefi

Mistakes in transjugular intrahepatic portosystemic shunt (TIPS) in cirrhosis and how to avoid them

Marco Senzolo

Colorectal cancer in young patients with Michael Bretthauer

Egle Dieninyte - Misiune

Mistakes in the management of peritoneal malignancies and how to avoid them

Charlotte Rabl

IBD in pregnancy with Mette Julsgaard - Part 2

Pradeep Mundre

UEG Online Course

New

accredited

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Oesophageal Cancer

Roos E. Pouw, Ana-Maria Bucalau

Summary

AI Generated

Summary is not available for this content yet.

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Overview

Oesophageal cancer (OC) is the 4^th most common gastrointestinal cancer. The incidence of OC is still rising, and it is associated with a poor 5-year survival. Early diagnosis and accurate staging of OC is important to decide on optimal treatment. Patients diagnosed in an early stage may be treated with minimally invasive endoscopic resection, whereas more advanced OC is usually treated with a multimodal approach, which may include chemotherapy, radiotherapy, surgery, and most often a combination of these. In patients in whom curative treatment is bit possible, palliative treatment can be applied to relieve complaints, mostly dysphagia. All aspects of OC—from subtypes, epidemiology, clinical presentation, diagnosis, staging, treatment and outcomes—are covered in this online course by Roos Pouw, Jessie Elliot and Ana Maria Bucalau. The course includes comprehensive PPT slides and bespoke video presentations, which were filmed in Vienna in 2026. Two real-life cases are included for consideration.

Target audience
This course is suitable for gastroenterologists (in training), but is also appropriate surgeons, physicians in other disciplines, nurses, and advanced-years’ medical students who have an interest in gastroenterology.

Event

Oesophageal Cancer

Topics

Digestive Oncology Oesophagus

Accreditation status

accredited

Duration

1 hour

Published

2026

More Like This:

Oesophageal Cancer

Ana-Maria Bucalau

Obesity part 1: Surgical and endoscopic treatment

Alia Hadefi

Mistakes in transjugular intrahepatic portosystemic shunt (TIPS) in cirrhosis and how to avoid them

Marco Senzolo

Colorectal cancer in young patients with Michael Bretthauer

Egle Dieninyte - Misiune

Mistakes in the management of peritoneal malignancies and how to avoid them

Charlotte Rabl

IBD in pregnancy with Mette Julsgaard - Part 2

Pradeep Mundre

UEG Online Course

New

accredited

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Obesity part 1: Surgical and endoscopic treatment

Alia Hadefi, Francesco Saverio Papadia

Summary

AI Generated

Summary is not available for this content yet.

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Overview

Nearly six in ten European adults are living with overweight or obesity, and more than 1.2 million deaths a year across the region are attributable to it. In this course, Alia Hadefi (Brussels) and Francesco Saverio Papadia (Genoa) take you through the endoscopic and surgical management of severe obesity, from first referral to lifelong follow-up.

Part 1 opens with the 2025 Lancet Commission distinction between preclinical and clinical obesity, then reviews the endoscopic bariatric and metabolic therapies: intragastric balloons, endoscopic gastric remodelling with the Apollo, Endomina and POSE platforms, and small bowel devices such as the duodenal-jejunal bypass liner and duodenal mucosal resurfacing. Dedicated sessions cover endoscopic sleeve gastroplasty in MASH and revisional endoscopy for weight regain after surgery.

On the surgical side, the course sets out current IFSO/ASMBS referral thresholds, how to match sleeve gastrectomy, Roux-en-Y gastric bypass and hypoabsorptive procedures to the individual patient, preoperative optimisation and ERAS, and the atypical presentation of leaks and internal hernia. It closes with nutritional monitoring, management of gastro-oesophageal reflux disease and weight regain, combination therapy with anti-obesity medications, and a round-table on where drugs, endoscopy and surgery are heading. Part 2, on pharmacological treatment, follows in 2027.

Target Audience:

This course is suitable for:

Gastroenterologists
Bariatric surgeons
Endocrinologists
Hepatologists
Dietitians
Bariatric nurse specialists
Medical students

The Online Course on "Obesity part 1: Surgical and endoscopic treatment" is kindly supported by Boston Scientific.
Their support has been received as financial contributions only, toward the administration and technical development of these initiatives.

The development of educational content, the programme and speaker selection remain solely with UEG.

Event

Obesity part 1: Surgical and endoscopic treatment

Topics

Endoscopy Surgery

Accreditation status

accredited

Duration

1 hour

Published

2026

More Like This:

Oesophageal Cancer

Ana-Maria Bucalau

Obesity part 1: Surgical and endoscopic treatment

Alia Hadefi

Mistakes in transjugular intrahepatic portosystemic shunt (TIPS) in cirrhosis and how to avoid them

Marco Senzolo

Colorectal cancer in young patients with Michael Bretthauer

Egle Dieninyte - Misiune

Mistakes in the management of peritoneal malignancies and how to avoid them

Charlotte Rabl

IBD in pregnancy with Mette Julsgaard - Part 2

Pradeep Mundre

UEG Mistakes In Articles

New

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Mistakes in transjugular intrahepatic portosystemic shunt (TIPS) in cirrhosis and how to avoid them

Kymentie Ferdinande, Alberto Zanetto, Virginia Hernández-Gea, Marco Senzolo

Summary

AI Generated

Summary is not available for this content yet.

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

TIPS success is rarely about the procedure alone. It depends on decisions made across the entire clinical pathway.

New in the UEG "Mistakes in…" series: Ferdinande et al., present 10 common mistakes in TIPS for cirrhosis, from referral to long-term follow-up.

Key themes:

• Screen the heart first: cardiac decompensation follows TIPS in up to 20% of patients.

• Refer early: delay costs survival in refractory ascites and high-risk variceal bleeding.

• Prevent encephalopathy by design: careful selection, nutrition, rifaximin, and controlled underdilation.

• Individualise haemodynamic targets and follow up structurally.

Topics

Hepatobiliary Surgery

Published

2026

More Like This:

Oesophageal Cancer

Ana-Maria Bucalau

Obesity part 1: Surgical and endoscopic treatment

Alia Hadefi

Mistakes in transjugular intrahepatic portosystemic shunt (TIPS) in cirrhosis and how to avoid them

Marco Senzolo

Colorectal cancer in young patients with Michael Bretthauer

Egle Dieninyte - Misiune

Mistakes in the management of peritoneal malignancies and how to avoid them

Charlotte Rabl

IBD in pregnancy with Mette Julsgaard - Part 2

Pradeep Mundre

UEG Podcast Episode

UEG Podcast

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Colorectal cancer in young patients with Michael Bretthauer

Michael Bretthauer, Egle Dieninyte - Misiune

Summary

AI Generated

Summary is not available for this content yet.

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Topics

Digestive Oncology

Published

2026

More Like This:

Oesophageal Cancer

Ana-Maria Bucalau

Obesity part 1: Surgical and endoscopic treatment

Alia Hadefi

Mistakes in transjugular intrahepatic portosystemic shunt (TIPS) in cirrhosis and how to avoid them

Marco Senzolo

Colorectal cancer in young patients with Michael Bretthauer

Egle Dieninyte - Misiune

Mistakes in the management of peritoneal malignancies and how to avoid them

Charlotte Rabl

IBD in pregnancy with Mette Julsgaard - Part 2

Pradeep Mundre

UEG Mistakes In Articles

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Mistakes in the management of peritoneal malignancies and how to avoid them

Francesco Saverio Papadia, Matteo Santoliquido, Andrea Barberis, Tarkan Jäger, Charlotte Rabl

Summary

AI Generated

Summary is not available for this content yet.

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Peritoneal malignancies represent a complex and often misjudged clinical challenge. Historically synonymous with a terminal diagnosis, the advent of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) radically altered the prognosis for selected patients. However, progress has been jeopardised by a series of recurring and preventable errors in diagnosis, staging, and treatment selection. This article delineates the ten most critical pitfalls in managing peritoneal surface malignancies. For each pitfall, we provide evidence-based explanations, concrete clinical examples, and strategic recommendations for avoidance. We emphasise the pivotal role of early multidisciplinary discussion, precise imaging, and timely referral to high-volume expert centres to optimise patient outcomes and offer curative intent where previously there was none.

Topics

Digestive Oncology Surgery

Published

2026

More Like This:

Oesophageal Cancer

Ana-Maria Bucalau

Obesity part 1: Surgical and endoscopic treatment

Alia Hadefi

Mistakes in transjugular intrahepatic portosystemic shunt (TIPS) in cirrhosis and how to avoid them

Marco Senzolo

Colorectal cancer in young patients with Michael Bretthauer

Egle Dieninyte - Misiune

Mistakes in the management of peritoneal malignancies and how to avoid them

Charlotte Rabl

IBD in pregnancy with Mette Julsgaard - Part 2

Pradeep Mundre

UEG Podcast Episode

New

UEG Podcast

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

IBD in pregnancy with Mette Julsgaard - Part 2

Mette Julsgaard, Pradeep Mundre

Summary

AI Generated

Summary is not available for this content yet.

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Topics

Published

2026

More Like This:

Oesophageal Cancer

Ana-Maria Bucalau

Obesity part 1: Surgical and endoscopic treatment

Alia Hadefi

Mistakes in transjugular intrahepatic portosystemic shunt (TIPS) in cirrhosis and how to avoid them

Marco Senzolo

Colorectal cancer in young patients with Michael Bretthauer

Egle Dieninyte - Misiune

Mistakes in the management of peritoneal malignancies and how to avoid them

Charlotte Rabl

IBD in pregnancy with Mette Julsgaard - Part 2

Pradeep Mundre

The global reference point for the digestive health community

Platform Publisher

United European Gastroenterology

Wickenburggasse 1 1080 Vienna, Austria

Contact us

T: +43 1 997 1639

Legal

Terms & Conditions

Explore

My recommendations

My fields of interest

© 2026 United European Gastroenterology

Change fields of interest

These fields are selected based on the interests in your myUEG profile.

Select your fields of interest

Click the item to unselect it. You can select multiple items.